|Articles|October 1, 2010
- Pharmaceutical Technology-10-02-2010
- Volume 34
- Issue 10
Pharmaceutical Technology, October 2010 Issue (PDF)
Vaccine Manufacturing Reborn
Advertisement
Articles in this issue
over 15 years ago
This Again?over 15 years ago
An Overview of NanoCluster Powder Formulation Technologyover 15 years ago
Risk Mitigation in High-Potency Manufacturingover 15 years ago
The Direction of Injectable Drug Deliveryover 15 years ago
Needles' Days Are Numberedover 15 years ago
Report from Europeover 15 years ago
Buyers in Short Supplyover 15 years ago
In the Spotlight October 2010over 15 years ago
An Unfocused Handbook on Environmental Monitoringover 15 years ago
Vaccine Manufacturing RebornNewsletter
Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.
Advertisement
Advertisement
Advertisement
Trending on Pharmaceutical Technology
1
Industry Outlook 2026: Trends Transitioning from 2025 into 2026
2
Amgen Acquires UK Biotech Dark Blue Therapeutics
3
The Benefits of an Immune-Directed ADC Strategy
4
Medable Presents AI Agent for Automating Trial Master File Processes at JP Morgan Healthcare Conference
5
